Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (pfizer) (intramuscular route)
About this medication
SARS-CoV-2 vaccine (mRNA-LNP, spike protein) is used as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 6 months of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This vaccine is to be given only by or under the direct supervision of your doctor. Monovalent Pfizer-BioNTech COVID-19 vaccine is no longer authorized for use in the United States. This product is available in the following dosage forms:
Before using this medication
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of SARS-CoV-2 (COVID-19) vaccine supplied invials with gray capsorvials with purple capsin children 12 years of age and older,vials with orange capsin children 5 to 11 years of age, andvials with maroon capsin children 6 months to 4 years of age. Safety and efficacy have been established. Appropriate studies have not been performed on the relationship of age to the effects of SARS-CoV-2 (COVID-19) vaccine supplied invials with gray capsorvials with purple capsin children younger than 12 years of age. Safety and efficacy have not been established. Appropriate studies have not been performed on the relationship of age to the effects of SARS-CoV-2 (COVID-19) vaccine in children younger than 6 months of age. Safety and efficacy have not been established. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of SARS-CoV-2 (COVID-19) vaccine in the elderly. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
How to use this medication
A nurse or other trained health professional will give you this medicine in a medical facility. It is given as a shot into one of your muscles. Primary series (for vaccines supplied in vials with maroon caps): This vaccine is usually given in 3 doses. The first 2 doses are given at least 3 weeks apart followed by a third dose given at least 8 weeks after the second dose. It is usually given to patients 6 months to 4 years of age. Tell your doctor if your child will turn from 4 years to 5 years of age between any doses in the primary series. Primary series (for vaccines supplied in vials with orange caps): This vaccine is usually given in 2 doses at least 3 weeks apart. Patients who have a weak immune system may receive a third dose at least 28 days after the first 2 doses. It is usually given to patients 5 to 11 years of age. Primary series (for vaccines supplied in vials with gray or purple caps): This vaccine is usually given in 2 doses at least 3 weeks apart. First booster dose (for vaccines supplied in vials with gray, purple, or orange caps): You may be given a first booster dose of Pfizer-BioNTech COVID-19 vaccine at least 5 months after your primary series with this vaccine. It is usually given to patients 5 years of age and older. A first booster dose of this vaccine may also be given to patients 18 years of age and older who have received primary vaccination with another authorized or approved COVID-19 vaccine (eg, Janssen COVID-19 vaccine or Moderna COVID-19 vaccine). Second booster dose (for vaccines supplied in vials with gray or purple caps): You may be given a second booster dose of Pfizer-BioNTech COVID-19 vaccine at least 4 months after your first booster dose with any authorized or approved COVID-19 vaccine. It is usually given to patients 12 years of age and older who have a weak immune system and to patients 50 years of age and older. This vaccine comes with a Fact Sheet for Recipients and Caregivers. Read and follow the information in the Fact Sheet carefully. Ask your doctor if you have any questions.
Disclaimer: August is a health information platform and its responses don't constitute medical advise. Always consult with a licenced medical professional near you before making any changes.